Getting a rejection notice from Meta for your peptide ads can feel like a dead end. You put time into the creative, set up the funnel, and suddenly the ad account is stalled. The good news is that most rejections are reversible with the right approach.
We have walked dozens of peptide and compounding pharmacy brands through the reinstatement process. Meta's automated review systems flag certain patterns consistently. Once you understand those patterns, you can fix them and get back online. The key is knowing what Meta's reviewers actually look for and how to structure your campaign to avoid triggering automated flags.
Why Meta Rejects Peptide Ads
Meta restricts advertising for health-related products. Peptides fall into a gray area that triggers extra scrutiny. The platform's automated systems scan ad copy, images, landing pages, and even account history before approving or rejecting an ad. Understanding what triggers those scans is essential for peptide advertisers.
The most common rejection triggers we see include references to specific medical conditions, before-and-after imagery, language that implies treatment or cure, and landing pages that discuss prescription-only products without proper disclaimers. Meta also scans for affiliate-style funnels that redirect to telehealth services.
Account-level history also matters. If your domain or business entity has been flagged before, new ads face higher scrutiny. This is why establishing clean business documentation upfront makes a significant difference in approval rates.
Policy Framework That Applies
Understanding the regulatory backdrop helps you build ads that last. The FDA's 503A and 503B frameworks govern compounding pharmacies and directly affect what you can claim in advertising. The Dietary Supplement Health and Education Act of 1994 (DSHEA) sets boundaries for supplement-related claims. Meta also enforces its own Community Standards and Advertising Policies, which restrict health claims and before-and-after imagery.
The BAV (Business Asset Verification) appeal pathway is your formal route to challenge a rejection. This involves submitting documentation that proves your business is legitimate and your products comply with applicable regulations. BAV verification is one of the most effective steps you can take because it establishes ongoing trust with Meta's review systems.
FDA 503A applies to traditional compounding pharmacies that prepare medications for individual patients based on a prescription. If you advertise under this framework, emphasize the service model: you offer compounding services, not pre-packaged drug products. FDA 503B covers outsourcing facilities that compound at scale, with additional requirements for sterility documentation.
How We Fix Rejected Peptide Ads
Audit the landing page first. Meta's reviewers look at your landing page with the same scrutiny as the ad itself. Remove any unsubstantiated health claims, add FDA 503A compliance language if applicable, and ensure your privacy policy and terms of service are clearly visible.
Rewrite the ad creative. Focus on educational language. Describe what peptides are and how compounding works without promising specific outcomes. Avoid words like cure, treatment, or therapy unless you have FDA-approved language to back them up.
Submit a detailed appeal. Use Meta's standard appeals process but include supporting documentation. Upload your business license, pharmacy license, and a written explanation of how your ad complies with both FDA regulations and Meta's policies.
Verify your business through BAV. The Business Asset Verification process requires you to connect your domain and business documents. This step alone often resolves recurring rejection issues because it establishes trust with the platform.
Case Study: Pharmacy Reversal in 72 Hours
A compounding pharmacy client came to us with a suspended ad account and 14 rejected ads. Their landing page mentioned specific peptide therapies for weight loss without any 503A disclaimers. We rebuilt the landing page with proper regulatory language, adjusted the ad copy to focus on educational content about compounded peptides, and submitted a BAV appeal with their pharmacy license. Within 72 hours, all 14 ads were approved and the account was reinstated.
More reading
Peptide Facebook Ads Disapproved
Why Are Peptide Ads Getting Banned
Ready to run these ads? Book a call at calendly.com/custodio-2/30min